Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203385 · ClinicalTrials.gov registry record · Phase 4
Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder
A Phase 4 study, sponsored by Tuscaloosa Research & Education Advancement Corporation.
- Terminated
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00203385 is a Phase 4 study that was terminated before completion, run by Tuscaloosa Research & Education Advancement Corporation. The registered enrollment target is 20 participants.
The verdict
NCT00203385, a Phase 4 study, was terminated before completion, sponsored by Tuscaloosa Research & Education Advancement Corporation.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The primary objective is to evaluate the long-term efficacy of divalproex sodium (Depakote) in the continuation treatment of PTSD.
Interventions
- DRUG Divalproex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2003-05 |
| Est. Completion | 2005-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00203385
The ClinicalTrials.gov registry entry for NCT00203385 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tuscaloosa Research & Education Advancement Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Divalproex is the first listed.
NCT00203385 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00203385 about?
NCT00203385 is a clinical study titled "Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder". The primary objective is to evaluate the long-term efficacy of divalproex sodium (Depakote) in the continuation treatment of PTSD.
What is the current status of trial NCT00203385?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2003-05. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00203385?
The interventions under investigation include: Divalproex (DRUG).
Who is sponsoring clinical trial NCT00203385?
This trial is sponsored by Tuscaloosa Research & Education Advancement Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.